menu
    • menu

    Company profile for Ondine Biomedical

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are focused on developing and commercializing novel antimicrobial therapies that address significant patient needs, are environmentally safe, provide substantial public health benefits, are easy to deploy and cost a fraction of the infections they target.Leading the charge in breakthrough photodisinfection-based therapies to prevent and treat a broad spectrum of infections, including those caused by superbugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ondine BiomedicalCanada Flag
    Country
    Country
    Canada
    Address
    Address
    888-1100 Melville Street Vancouver, BC V6E 4A6
    Telephone
    Telephone
    604.669.0555
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ondinebio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ondine And Mid Yorkshire Teaching NHS Trust Shortlisted
    Ondine And Mid Yorkshire Teaching NHS Trust Shortlisted

    23 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-23/ondine-and-mid-yorkshire-teaching-nhs-trust-shortlisted-for-excellence-in-healthcare-partnership-award-for-reducing-surgical-site-infections-with-nas

    PHARMIWEB
    23 Dec 2025
    Share Share
    Steriwave Now Protecting Patients With Cancer
    Steriwave Now Protecting Patients With Cancer

    24 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-24/steriwave-now-protecting-patients-with-cancer

    PHARMAWEB
    24 Sep 2025
    Share Share
    Steriwave Proven to be Effective Against C. Auris.
    Steriwave Proven to be Effective Against C. Auris.

    16 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-16/steriwave-proven-to-be-effective-against-c-auris

    PHARMAWEB
    16 Sep 2025
    Share Share
    Ondine's Steriwave® Health Economics Study Chosen for ICPIC 2025
    Ondine's Steriwave® Health Economics Study Chosen for ICPIC 2025

    04 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-04/health-economics-study-on-ondine-s-steriwave-selected-for-oral-presentation-at-icpic-2025-in-geneva

    PHARMAWEB
    04 Sep 2025
    Share Share
    Ondine Biomedical - Study Suggests £200M UK Savings
    Ondine Biomedical - Study Suggests £200M UK Savings

    09 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/ondine-biomedical-inc-economic-study-suggests-c200-million-uk-savings-1012639

    ACCESSWIRE
    09 Apr 2025
    Share Share
    Ondine Biomedical - Study Shows c.£200M UK Savings
    Ondine Biomedical - Study Shows c.£200M UK Savings

    09 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/ondine-biomedical-inc-economic-study-suggests-c200-million-uk-savings-1012639

    ACCESSWIRE
    09 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search